Skip to main content

Retail Clinics

  • Actavis to reintroduce FeverAll

    MORRISTOWN, N.J. Actavis on Tuesday announced the reintroduction of its FeverAll acetaminophen suppositories to retail following the completion of updates to the company’s manufacturing facility.

    The brand will be marketed in publications read by new parents and healthcare professionals, the company stated.

     

  • Take Care Health Systems praises declaration of NCCCW

    CONSHOHOCKEN, Pa. Take Care Health Systems has praised the designation of National Convenient Care Clinic Week by Sens. Dan Inouye, D-Hawaii, and Thad Cochran, R-Miss.

    National Convenient Care Clinic Week plays out against the backdrop of the third annual Retail Clinician Education Congress, co-hosted by The Drug Store News Group/Retail Clinician magazine and the Convenient Care Association.

  • FDA approves Merz's Xeomin

    GREENSBORO, N.C. The Food and Drug Administration has approved a treatment for muscle spasms and twitches.

     

  • Sagent's generic Imitrex receives regulatory approval

    SCHAUMBURG, Ill. The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals for treating migraine attacks, Sagent said Monday.

     

    The FDA approved Sagent’s sumatriptan succinate injection in the 6 mg per 0.5 milliliter strength. The drug is used to treat acute migraine attacks and cluster headache episodes.

     

     

    Sumatriptan is a generic version of GlaxoSmithKline’s Imitrex. Injectable sumatriptan had $22 million in sales in 2009, according to IMS Health.

  • NACDS urges FDA to move carefully in risk management rules for opioids

    ROCKVILLE, Md. Note to the Food and Drug Administration from the chain pharmacy industry: when it comes to beefing up oversight and regulation of some high-risk medications, slow and steady is the best approach.

  • Sandoz first to receive FDA approval for Lovenox generic

    SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

     

    The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

     

     

  • Beacon Community program seeks to curb diabetes across country

    WASHINGTON Vice President Joe Biden and the Department of Health and Human Services secretary Kathleen Sebelius have announced a pilot program designed to curb diabetes in 15 selected U.S. cities with the help of health-information technology.

  • Mylan markets generic Solodyn ER

    PITTSBURGH Mylan has launched a generic treatment for acne, the company said Thursday.

    Mylan announced the launch of minocycline hydrochloride extended-release tablets in the 45 mg, 90 mg and 135-mg strengths. The drug is a generic version of Solodyn ER, made by Medicis Pharmaceuticals Corp.

     

    Minocycline ER had sales of around $496 million during the 12-month period ended in March, according to IMS Health.

     

X
This ad will auto-close in 10 seconds